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Resumen: El compuesto nifedipina es prácticamente insoluble en agua y 
consecuentemente no se alcanza todo el potencial de sus propiedades. Para superar 
estas limitaciones, se utiliza la técnica de dispersión sólida. Sin embargo, formulaciones 
en estado amorfo obtenidas tienden a recristalizar. 
Se estudiaron diferentes factores influyentes en la recristalización. De acuerdo a la 
composición de la formulación, cuanta menor concentración del compuesto 
farmacéutico, mayor es el tiempo para cristalizar. Respecto a la humedad relativa (RH), 
existe una gran diferencia entre los valores iniciales y finales de agua absorbida en los 
experimentos con las RH implementadas. Respecto a la temperatura, cuanto menor es la 
temperatura, mayor es tiempo necesario para alcanzar el equilibrio. También se llevaron 
a cabo experimentos cambiando el polímero y el modo de preparar la formulación. 
Para caracterizar las muestras se utilizaron Powder X-Ray Diffraction (PXRD), Differential 
Scanning Calorimetry (DSC) y espectrofotómetro. 
La ecuación de Avrami ha demostrado su validez para modelar el comportamiento 
seguido por la cristalización. 
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Abstract 
 
The goal of this master project is to study the crystallization of nifedipine from water content 
absorbed by analyzing different influencing: active pharmaceutical ingredients (API) weight 
fraction, temperature, relative humidity (RH), polymer and the method to prepare the 
formulation.  
The drug is practically insoluble in water, consequently its properties do not reach its full 
potential. To overcome these limitations, the solid dispersion method was the solution. It was 
originally used to improve the dissolution properties and the bioavailability of poorly water 
soluble drugs by dispersing them into water soluble carriers. 
The amorphous solid dispersions were prepared by spray drying method with a Büchi Mini 
Spray Dryer B-290. 
When preparing the formulation, the same steps were always followed in order to have the 
same thermodynamic history for all the samples. When preparing the amorphous solid 
dispersion, acetone was used as solvent. The inlet temperature was 60 °C and the outlet 
temperature was in a range of 35-40 °C. 
After spray drying or melting method, the results show that the solid dispersions were totally 
amorphous. In order to characterize the solid state of the sample, powder X-ray diffraction 
(PXDR) and differential scanning calorimetry (DSC) were used.   
The Avrami equation has proved its validity to model the behavior followed by the 
crystallization. The parameters obtained agree with the results achieved from the suspension 
balance experiments. It has been shown that the assumption of n parameter equal to 4, which 
is crystal growth in 3 dimensions, is correct. 
According to the API weight fraction, the lower API concentration the sample contains, the 
longer it takes to crystallize. It could be the case that with that weight fraction does not reach 
the recommended dose, in that case it would have to reach a compromise between the weight 
fraction and the improved properties achieved and the recommended dose. On the other side, 
future investigations would go in the direction of studying lower API weight fractions.  
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In terms of relative humidity, a huge difference occurs among the several relative humidities 
that have been implemented. These differences translate into variations in the time required to 
reach the equilibrium and crystallize and the initial and final water content. 
Regarding to the temperature, the lower temperature under the sample is at, the longer it takes 
to crystallize. Thereby, in order to avoid crystallization, it is necessary to operate under a 
minimum temperature. 
In respect of the method to prepare the formulation, differences in time to crystallize emerged. 
Thus, the time needed for the melting method, which is normally used in industry, is less than 
the time required for spray drying method. In this manner, in order to avoid crystallization, it 
might be considered a way to use and optimize the spray drying method on a large scale. 
Respecting the polymer used in the formulation, it was noticed that PVAC retarded the time 
to crystallize so that it better fulfills the purpose of avoiding crystallization than Resomer 
R203s. In further investigations, more polymers will have to be studied in order to find the 
optimum. 
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List of symbols 
 
Symbol Interpretation 
wAPI Weight fraction of API 
wNIF Weight fraction of Nifedipine 
Tin Inlet temperature 
Tout Outlet temperature 
 
 
 
 
List of abbreviations 
 
Abbreviation Interpretation 
API Active Pharmaceutical Ingredient 
NIF Nifedipine 
FDA Food and Drug Administration 
RH Relative humidity 
PXRD Powder X-Ray Diffraction 
DSC Differential Scanning Calorimetry 
UV-Vis Ultra Violet – Visible 
A Absorbance 
VLE Vapor Liquid Equilibrium 
SVLE Solid Vapor Liquid Equilibrium 
PVAC Polyvinyl acetate of molecular weight 90.000 
g/mol 
PVAC350 Polyvinyl acetate of molecular weight 
350.000 g/mol 
SD Solid dispersion 
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1. Aim of the project  
 
Nifedipine (NIF) is a calcium channel blocker, widely used clinically as a coronary 
vasodilator. Pharmaceutical preparations are available as capsules, tablets, and solutions, and 
the drug is usually administered orally or intravenously. The drug is practically insoluble in 
water, and is reported to be highly light sensitive 
The current way of administration implicates a number of weaknesses. In fact, NIF is usually 
provided as solution using liquid oral drug preparation or by cutting a soft gelatin capsule and 
by squeezing out the fluid content beneath the tongue [1]. This mode of administration can 
lead to dosage and assimilation variability. The administration of NIF solid dispersions (SD), 
by using a suitable polymeric carrier, comes out an interesting modus operandi in order to 
progress into a better dose precision, residence time and patient compliance. 
The SD method was initially used to ameliorate the dissolution properties and the 
bioavailability of poorly water soluble drugs by dispersing them into water soluble carriers. 
Dissolution deceleration through SD method using water insoluble polymer for the 
development of controlled release dosage forms has become a field of interest in latest years 
[2]. 
The progress of controlled release SD has a great advantage for avoiding the risk of a sudden 
release of drug; as the structure of the solid dispersion allow a homogeneous dispersion of the 
drug molecules [2]. 
Amorphous formulations have attracted considerable attention in the pharmaceutical field. As 
the molecular structures of drug candidates become increasingly complex, solubility often 
becomes a limiting factor in dissolution and oral absorption. The use of the amorphous form 
is a promising strategy to battle these limitations due to its higher free energy and, therefore, 
higher apparent solubility than its crystalline equivalent. However, such amorphous 
formulations are metastable and tend to convert spontaneously to the crystalline state. 
When crystallization occurs during processing, or during the shelf-life of the pharmaceutical 
product, bioavailability and product efficacy may be adversely affected. Therefore, an 
understanding of the crystallization kinetics from the amorphous state and the prediction of 
physical instability are important in the pharmaceutical industry. 
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Long term stability tests are imposed by Food and Drug Administration (FDA) at defined 
Temperature and relative humidity (RH) conditions with which their long term stability is 
verified and the appropriate polymer and concentration for the formulations are acquired.  
 
The aim of this master thesis is to study the crystallization velocity of NIF formulations from 
the water content absorbed analyzing different influencing factors: active pharmaceutical 
ingredient (API) weight fraction, temperature, RH, polymer and the method to prepare the 
formulation. It brings into focus the characterization of the ternary system (API-polymer-
water). 
Finally, the predicted crystallization profiles are calculated and compared with the 
experimental results obtained. 
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2. Theory  
 
An API is the chemical compound of any formulation which is pharmaceutically active. Some 
formulations, such as integration treatment, have multiple active ingredients to treat different 
diseases. 
All drugs are made up of two core elements: the API, which is the central ingredient, and the 
excipient, the substance inside the drug that helps deliver the medication to the desired place 
within the organism. Excipients are inactive substances, such as polymers, and not chemically 
active.  
According to the U.S. Food and Drug Administration, an API is defined as: 
“Any substance or mixture of substances intended to be used in the manufacture of a drug 
product and that, when used in the production of a drug, becomes an active ingredient in the 
drug product. Such substances are intended to furnish pharmacological activity or other direct 
effect in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the 
structure and function of the body.” [3]. 
 
2.1 Stabilization of APIs in polymeric matrices (solid dispersions) 
 
Amorphous formulations have attracted considerable interest in the pharmaceutical field as a 
way of improving bioavailability [2,4]. As the molecular structures of drug candidates 
become increasingly complex, solubility often becomes a limiting factor in dissolution and 
oral absorption.  
The crystalline state is thermodynamically the most stable solid state, and is characterized by 
both lower solubility and higher chemical stability [30]. 
When crystallization occurs during processing, or during the useful life of the pharmaceutical 
product, bioavailability and product efficacy may be adversely affected. 
The process of crystallization is known to be composed of two major steps: nucleation and 
crystal growth, and the rates are generally governed by molecular mobility affecting the 
diffusion rate of molecules and thermodynamic factors such as the Gibbs free energy and 
nucleus/amorphous interfacial energy.  
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Preparation of poorly water-soluble APIs into amorphous forms improves their solubility. 
However, amorphous solids are often physically metastable because of their high energy state, 
and crystallization during storage presents a problem.  
A promising strategy to improve the dissolution limited bioavailability would be to use the 
amorphous state and take advantage of the higher solubility of this high free energy state. On 
the other hand, because amorphous drugs are in a higher free energy state than a 
corresponding crystalline state, re-crystallization is thermodynamically favored. 
The phase behavior of solid dispersions can be extremely complicated, whereby the API can 
potentially be present in its crystalline state (which may involve one or more polymorphic 
forms) or as a fully or partially amorphous form. For amorphous solid dispersions, one 
important aspect of the phase behavior is the miscibility of the amorphous phases of the drug 
and the polymeric carrier. 
 
2.1.1 Methods of preparation 
 
There are numerous methods to prepare a solid dispersion. Below it is proceed to describe 
some of them [2]: 
 
Spray drying 
Spray drying is a unit operation capable of transforming solutions or suspensions into a solid 
product. The spray drying technique comprises four basic steps: atomization of the liquid, 
mixing of the liquid with the drying gas, evaporation of the liquid and separation of the dried 
particles from the gas [2]. 
The liquid solution is transferred from the beaker to the nozzle entrance by a pump system. In 
case of solid dispersion preparation, the used solvents are mostly organics. 
As the slurry enters the tower, it is atomized into fine droplets. Partly because of the high 
surface tension of water and partly because of the hydrophobic/hydrophilic interactions 
between the amphipathic carrier, the water and the load, the atomized slurry forms micelles.  
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Several types of atomization devices are available, depending on the type of energy that is 
involved: centrifugal energy, pressure energy, kinetic energy and vibrations. 
All spray dryers use some type of atomizer or spray nozzle to disperse the liquid or slurry into 
a controlled drop size spray. The most common of these are rotary disk and single-fluid high 
pressure swirl nozzles.  
The small size of the drops (averaging 100 micrometers in diameter) results in a relatively 
large surface area which dries quickly. As the water dries, the carrier forms a hardened shell 
around the load. The final product is removed from the gas phase in a cyclone and collected in 
a cyclone at the end of the process [5] 
 
A general scheme for a spray drying equipment is depicted in the following Figure 1:  
 
 
Figure 1. Scheme of spray drying method [6] 
 
Melting method 
The melting method involves melting of a physical mixture of drug and carrier to the liquid 
state followed by cooling until solidiﬁcation [2]. It is the simplest method which can be used, 
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one of the advantages is that it is a solvent free method. However, the API and the excipient 
should be miscible and mixed well [4]. 
 
Melting solvent method 
The melting solvent technique is a combination of the solvent evaporation method and 
melting method [2]. 
It is carried out by the dissolution of the drug in an appropriate solvent and the mixture of this 
solution with the molten carrier followed by cooling for solidiﬁcation. The advantage of this 
method is that it needs inferior temperatures with lesser risk of decomposition of thermolabile 
drugs than other methods. 
 
Solvent evaporation method 
This technique consists of dissolving the drug and excipient simultaneously in a common 
solvent, followed by the withdrawal of the solvent by evaporation. 
Many drugs and carriers cannot be utilized for others methods, such as melting method, due to 
their high melting points, then they can be used for solvent evaporation method [2]. 
 
Hot melt extrusion 
The advantages of this technique include lower temperature than other methods and shorter 
residence time of the drug carrier mixture. The physical mixture of drug and excipient is 
moved into the heated chamber of extruder at a controlled rate. 
Since the physical mixture is carried through heated screws, it is melted, which allows 
homogeneous mixing. In the last step of the process the melt is shaped in the required form 
such as granules, pellets, tablets, powder [4].  
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The following Figure 2 shows a general outline of the process: 
 
 
Figure 2 Hot melt extrusion process [7] 
 
Supercritical antisolvent method 
It is said a single fluid phase is supercritical when it is above its critical pressure and 
temperature. Carbon dioxide is the most used supercritical fluid. 
Several terms are used according to the technique by which supercritical fluid and solution are 
mixed: (1) precipitation from supercritical solutions by fast expansion of supercritical 
solution, (2) precipitation from saturated solution using supercritical ﬂuid as an antisolvent, 
(3) precipitation from gas saturated solutions [2]. 
 
2.1.2 Solid state characterization 
 
Owing to the importance of the nature of solid dispersions, either crystalline or amorphous 
state, it is needed to verify which state has been achieved both at the beginning and at the end 
of each experiment. 
For this reason, several techniques have been used. These are Powder X-Ray Diffraction 
(PXRD) and Differential Scanning Calorimetry (DSC) since they are the most generally used 
techniques to define the solid state. Spectrophotometer has been used in order to measure the 
real API weight fraction of the formulation.  
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PXDR is a technique using X-Ray to illustrate the crystalline state of materials. The scattering 
of X-rays from atoms produce a diffraction pattern that contains information about the atomic 
structure. Amorphous materials do not produce any significant peak in diffraction pattern, 
while crystalline materials are completely the opposite as it can be seen in Figures 3 and 4 [8].  
 
 
Figure 3. PXDR pattern of an amorphous sample (wNIF 70%) 
 
 
Figure 4. PXDR pattern of a recrystallized sample (wNIF 80%, PVAC350, 40°C, 75%RH) obtained 
after the suspension balance experiment 
 
DSC is an analytical technique in which the difference in heat flow between a sample and an 
inert reference is measured as a function of time and temperature as both are subjected to a 
controlled environment of time and temperature [9].  
DSC analyses give information about melting temperature and enthalpy by the study of 
endothermic peak as illustrated in Figure 5, and its crystallinity composition. 
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Figure 5. DSC thermogram of NIF/PVAC (wNIF 70%, PVAC, 40°C, 75%RH) 
 
A UV-VIS Spectrophotometer has been used to measure the absorbance at a particular 
wavelenght in order to verify the composition of both components at the end of experiment. 
 
2.2 Phase behavior of API/polymer-formulations 
 
In this section, it will be discussed the phase behavior of API-polymer formulations. The 
phase behavior of the system depends on the conditions in which the work is being done, 
thereby different cases can be found.  
The knowledge of the phase behavior is of great interest for practical application. When 
recrystallization or an amorphous phase separation of the API / polymer system is observed, 
the end of the shelf life of the formulation is achieved. 
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The stability of the mixture is determined by the solubility. The maximum quantity of API 
that can be dissolved in the polymer without crystallization is the API solubility in the 
polymer and thus depends on the phase behavior of the resulting API/polymer formulation. 
 
 
Figure 6. Behavior of solubility against temperature and API weight fraction [10] 
 
As it can be seen in Figure 6, solubility separates two contrasting areas. Below the solubility 
concentration the API-polymer formulation is stable and at API concentrations higher than the 
solubility, the system tends to crystallize as it is supersaturated and unstable. 
On the other hand, it also affects the miscibility gap between the compounds. Therefore it can 
be distinguished several zones as it can be seen in Figure 7. The green area (upper area) 
corresponds to the stable zone in which the system is in amorphous state. In the purple sector 
(upper inner area of the miscibility curve), it is found two liquid phases corresponding to 
polymer and water. In the dark orange sector (lower area) within the miscibility gap, it is 
found two liquid phases as in the previous sector and recrystallization may occur as well. 
Finally in the light orange area there is recrystallization as the concentration is greater than the 
solubility [10]. 
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Figure 7. Behavior of solubility and present phases against temperature and weight fraction [10] 
 
If a high API concentration is present, the solubility of the API in the polymer/water mixture 
is exceeded, the API recrystallizes and a vapor-solid-liquid equilibrium ensues. 
It is assumed that the vapor phase still consists exclusively of water. In the liquid phase 
amorphous API and polymer as well as sorbed water are present. The solid phase consists of 
pure crystalline API. The recrystallization of the API reduces the API concentration in the 
liquid phase, which in turn affects the water absorption. 
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The evolution of the water weight fraction from the amorphous to crystalline state can be 
followed in the next Figure 8. 
 
In the next Figure 9, it can be observed the evolution of solubility in this specific case of a 
Nifedipine-PVAC sample in conditions of 40°C and 75% RH. 
 
Figure 9. Behavior of NIF solubility [10] 
 
 
 
Figure 8. Evolution of water weight fraction: (a) initial curve for amorphous formulation at 
temperature I, (b) at temperature II, and (c) at temperature III [10] 
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2.3 Influence of humidity on the phase behavior  
 
In this chapter, it will be discussed the effect of humidity in the polymer-API system as it is 
being studied the crystallization by the water absorbed. Amorphous solid dispersions are 
prone to absorb water which drives to crystallization of API. Both the API solubility and 
water sorption depends on type of API and polymer on the formulation, as well as the 
temperature and the RH [10].  
The water sorption of the formulations depends on the physical state of them. Phase 
transformations can be observed as function of time. 
 
 
 
Figure 10. Behavior of water content and phases during crystallization for a wNIF 70% [10] 
 
As it can be seen in the previous Figure 10, the maximum value of water weight fraction 
corresponds to amorphous nature and as time goes on the sample begins to crystallize until 
reaching the minimum possible water value [11].  
As the relative humidity of the amorphous system was increased, a decrease in the glass 
transition temperature was noticed indicating an increase in molecular mobility which leads to 
a faster crystallization [12] 
Therefore, on the one hand, water absorbed from the vapor phase induces API crystallization; 
and on the other hand, the crystallinity of the API/polymer system determines the quantity of 
water which is absorbed. 
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2.4 Estimation of crystallinity via mass balances and water sorption 
 
In order to estimate the crystallinity of the sample from the water sorption, obtained from the 
suspension balance experiments, it is necessary to make use of mass balances and Vapor-
Liquid-Equilibrium (VLE) and Solid-Vapor-Liquid-Equilibrium (SVLE). 
Regarding to the mass balances, it was required to implement a global mass balance to the 
whole system and a mass balance to every substance taking into account the two existing 
phases: solid and liquid. 
One assumption taken is that the water is absorbed only by the amorphous liquid phase. The 
solid phase consists exclusively of crystalline API, polymer and water are insoluble in the API 
crystal. 
Furthermore, the mass of the amorphous polymer in the liquid phase of the water-free system 
is equal to the mass of polymer in the water-loaded system. 
 
The mass of API in the saturated liquid phase and in the crystalline solid corresponds to the 
mass of the API in the water-free system. 
 
Global mass balance: 
 
              (1) 
 
In this expression,          mean the total liquid and solid phase respectively. 
Water mass balance: 
 
  
        
    
   (2) 
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In which the total water mass is the sum of water mass in the liquid phase and the water mass 
in the solid phase. This last one is equal to zero,  
   , due to it was assumed that the solid 
phase, that is the crystals, is completely composed by NIF. 
On the other hand, the liquid water mass depends on the absorbed water weight fraction and 
the formed crystal percentage per total mass        . 
 
  
   
     
         
 (3) 
 
Polymer mass balance: 
 
        
              
          
   (4) 
 
Where the polymer total mass is equal to the sum of polymer liquid phase mass and the 
polymer solid phase mass. As it was said before, as it was assumed that the solid phase is 
completely composed by API, then the polymer mass in the solid phase is zero. 
 
        
     (5) 
 
And the polymer liquid phase weight fraction depends on the API and H2O weight fraction. 
        
        
    
   (6) 
 
API mass balance: 
    
          
      
      
          
        (7) 
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In this expression, the API total mass is equal to the addition of API liquid phase mass and 
API solid phase mass. As it was assumed that the solid phase is completely composed by 
nifedipine, then     
   .  
On the other side, the liquid phase weight fraction depends on the absorbed water and the API 
water free-liquid phase weight fraction (      
 ), which was obtained from the VLE. 
 
    
   
     
 
        
   (8) 
 
 
2.5 Calculation of activity coefficients via PC-SAFT 
 
The Perturbed-Chain Statistical Associating Fluid Theory (PC-SAFT) is an equation of state 
designed for modeling mixtures of all types of substances: gases, solvents and polymers. 
PC SAFT is satisfactory for the calculation of phase equilibrium and thermodynamic 
properties of pure components and mixtures. It is found to be more precise comparing to other 
equation of state (EoS) for correlation of experimental data and more predictive when applied 
to mixtures. It is very reliable for extrapolations over the regions where parameters were 
adjusted. Comparison to the original SAFT equation of state reveals significant improvement 
for both, mixtures of small components and polymer solutions [13].  
 
 
Figure 11. Interaction of the three components of the system 
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A huge advance in modeling phase behavior of polymer systems has been made during the 
last years with use of EoS. In many such theories chain-like molecules are modeled as chains 
of freely-jointed spherical segments.  
 
The PC-SAFT equation of state is based on perturbation theory with the hard chain as 
reference fluid. The perturbation contributions account for dispersive attractions as well as 
association interactions and the reduced residual Helmholtz energy [13]. 
 
In accordance with this model, molecules are determined by three pure component 
parameters: 
- Attraction parameter ε 
- Segment number m 
- Segment diameter σ  
 
In spite of its clarity, this molecular model considers the vital characteristics of real 
molecules. Those characteristics are: 
- Repulsive interactions 
- Non-spherical shape of molecules (chain formation) 
- Attractive interactions (dispersion) 
 
 
Figure 12. Interaction of the forces involved in the EoS 
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The hard chain contribution represents the repulsions between the molecules. The attractions 
of molecules are considered by dispersive interactions and strong hydrogen bonding which 
exists between the associating molecules. 
Therefore, the free residual energy a
res
 is calculated [14]:  
 
                        (9) 
 
Despite considerable work on further developments, one of the most successful models 
remains the original SAFT equation of state. However, in the dispersion term of the original 
SAFT model, the chain-like structure of polymer compounds is not taken into account. 
 
In the Perturbed-Chain SAFT equation of state, the dispersive forces are accounted for 
applying a perturbation theory of second order (Barker and Henderson), using an expression 
for the radial pair distribution function of a hard-chain reference fluid [13] 
 
For utilization of the PC-SAFT equation of state to real substances, the integral in the 
dispersion term is replaced by a power series in density, where the coefficients show a simple 
dependence on segment number. 
 
To characterize an associating substance, the number of association sites as well as their type 
has to be assigned according to the molecular structure. Five pure component parameters for 
associating substances have to be identified:  
 
Segment number:  
            (10) 
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Segment diameter:  
     
 
 
          (11) 
 
Dispersion energy parameter:  
                   (12) 
 
Association energy: 
      
 
 
               (13) 
 
Association volume: 
                     
        
           
 
 
  (14) 
 
 
2.6 JMAK equation 
 
In order to represent a model for the kinetics of crystallization, it has been used the Avrami 
equation. It describes the transformation of one phase from another by the growth of nuclei 
that are randomly formed in the primary phase.  
The Avrami equation is also known as Johnson Mehl Avrami Kolmogorov (JMAK) equation 
[15]. 
The crystallization is usually observed to follow a characteristic sigmoidal curve in which it 
can be differentiated three zones. At the beginning, the crystallization rate is slow as it is the 
time required for a significant number of nuclei of the new phase to form. The intermediate 
rate is fast since the nuclei formed in the previous step grow in size. And the final rate is slow 
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again since most of the compound has been crystallize and there is less material to convert, 
the particles already existing start to touch each other. 
 
 
Figure 13. Characteristic sigmoidal curve followed by crystallization [16] 
 
It has been assumed important simplifications to follow Avrami equation [17]: 
- Nucleation occurs randomly and homogeneously over the entire untransformed 
portion of the material. 
- Growth rate does not depend on the degree of transformation. 
- Growth happens at the same velocity in all directions, the growth is isotropic. 
 
Thus, the number of nuclei is based on the volume, the nucleation rate and the time interval in 
which it is measured. 
 
           (15) 
 
Developing this initial equation, the final equation is reached, the usual form of Avrami 
equation, which gives the fraction of crystals transformed. 
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                (16) 
 
Where   
                  
            
 
 
It can also be written as: 
 
       
 
   
              (17) 
 
This equation allows the estimation of the transformation constants, K and n, as it can be seen 
in the next Figure 14. 
 
 
Figure 14. Graph where the slope is the n parameter [17] 
 
K and n are transformation parameters. The n parameter depends on the dimension of the 
nuclei, and due to the assumptions made earlier, this parameter will be 4 [18]. 
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3. Materials and experimental methods  
 
3.1 Materials 
 
Nifedipine was purchased from Tokyo Chemical Industry CO., LTD. (Tokyo, Japan) with a 
purity of >98.0% 
Poly(vinyl acetate) (PVAC) of a molecular weight of 90.000 g/mol was acquired from  
Polysciences Inc. (Warrington, PA, USA). Poly(vinyl acetate) (PVAC) of a molecular weight 
of 350.000 g/mol was purchased from Scientific Polymer Products Inc. (Ontario, NY, USA). 
Resomer® R203 S was acquired from Evonik Industries (Darmstadt, Germany). 
Acetone with a purity of 99.9%, was purchased from VWR International GmbH (Darmstadt, 
Germany) was used to prepare the formulations of API and the polymers for spray drying. 
 
NIF is a yellow crystalline substance, practically insoluble in water but soluble in ethanol. It 
has a molecular weight of 346.3 g/mol and a melting point of 173 °C. 
NIF is an antianginal drug belonging to a class of pharmacological agents, the calcium 
channel blockers. NIF is used to treat hypertension (high blood pressure) and angina (chest 
pain). It works by relaxing the muscles of your heart and blood vessels. [19]. 
Nifedipine has the following structural formula [20]:  
 
Figure 15. Molecular structure of NIF 
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Polymorphism, that is the occurrence of chemical compounds characterized by the same 
structural formula but different crystal forms, is a phenomenon of fundamental importance in 
organic chemistry as different molecular structure may cause considerable variations in the 
physical and chemical properties of the compound such as the melting temperature or 
enthalpy. In the case of nifedipine, three polymorphs have been described: modification III, 
modification II (or β) and modification I (or α). Only β and α polymorphs are metastable and 
stable [21,22]. 
 
 
Figure 16. Molecular structure of NIF polymorphs [23] 
 
 
Table 1. Thermal properties of the different polymorphs [24] 
Properties α NIF β NIF 
Melting temperature (°C) 169-173 162-164 
Melting enthalpy (J/g) 104 71 
 
In order to differentiate the two polymorphs, it was also found the different behavior on 
heating and cooling. It can be appreciated, in Figure 17, the contract between the shape of the 
peaks and specially the temperatures at which those peaks occur. 
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Figure 17. Behavior of the two polymorphs on heating and cooling [23] 
 
According to the X-Ray diffraction, Figure 18 is the pattern of the β polymorph [23], which 
will be used later to distinguish them as well. 
 
Figure 18. Theoretical NIF pattern by PXRD  
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3.2 Experimental methods  
 
In the experimental procedure, different stages can be distinguished: 
 
 3.2.1 Preparation of formulations via spray drying 
 
The exact quantity of polymer and API contained in each sample was weighted by a balance 
from Sartorius (Göttingen, Germany) following the selected rates of 70%, 75%, 80%, 85%, 
90% NIF. Every sample was 1g. 
Next, 100 mL of acetone were added to the mixture to keep a rate of 1/100. Before 
performing the spray dying, it was needed to stir the solution in order to have it completely 
dissolved and homogeneous. 
In order to perform the solid dispersion preparation, a Mini Spray Dryer B-290 from Büchi 
has been used. 
Firstly, a nitrogen flow was fed into the equipment, so the oxygen inside decreases, to set up 
inert conditions in the spray dryer. Regarding to aspiration, it was established at a value of 
90% of the total capacity of the system. 
Once the system was under inert conditions, the heater was started; the selected inlet 
temperature was 60°C, with which 35-40 °C was reached as outlet temperature. After the 
selected inlet temperature was achieved, the equipment was drained with pure acetone for 5 
minutes to get the drying conditions. The pump rate was set at a point of 30% of its capacity. 
Afterwards, the spray dryer method started when the pure solvent was switched to the 
previously prepared solution. At the end of the process, it was switched back to acetone to 
clean nozzle and tubes. 
Finally, the powder resulting from the process was collected with a plastic spoon and stored in 
a small container. 
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Figure 19. Büchi Mini Spray Dryer B-290 experimental installation 
 
 
 3.2.2 Suspension balance experiments 
 
The suspension balance is the equipment where the water sorption and recrystallization have 
taken place. Once the solid dispersion was ready from spray drying, the sample was brought 
here immediately.  
Firstly, the solid dispersion was placed in a glass pan which went to the interior of the 
chamber. Here, the working conditions were vacuum with respect to pressure and the selected 
temperature during 2 hours, the time needed to reach equilibrium, in order to dry the sample. 
Once the equilibrium is achieved, the operating conditions were changed. The pressure was 
established according to the percentage of required relative humidity and vapor pressure of 
water at the chosen temperature. 
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The experiments concluded when the equilibrium was achieved. 
 
 
Figure 20. Suspension balance experimental installation 
 
 
In the following table, all the experimental conditions are presented. 
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Table 2. Conditions of the experiments in suspension balance 
API weight fraction (%) Polymer Temperature (°C) RH (%) 
90 PVAC 40 75 
80 PVAC 40 75 
70 PVAC 40 75 
90 PVAC 30 75 
80 PVAC 35 75 
90 PVAC 35 75 
70 PVAC 35 75 
80 PVAC 40 90 
80 PVAC 40 60 
80 PVAC 40 75 
80 PVAC350 40 75 
80 PVAC350 40 75 
90 PVAC350 40 75 
80 Resomer 203s 40 75 
70 Resomer 203s 40 75 
90 Resomer 203s 40 75 
85 PVAC 40 75 
75 PVAC 40 75 
80 PVAC (Melting) 40 75 
70 PVAC (Melting) 40 75 
80 PVAC 40 75 
80 PVAC 30 75 
80 PVAC350 40 75 
90 PVAC 40 75 
 
 
 3.2.3 Verification of crystallinity via PXRD and DSC 
 
The PXDR measurements have been carried out by Miniflex 600 from Rigaku (Tokyo, Japan) 
in order to determine if the solid dispersions were amorphous right after the spray drying and 
crystalline after the suspension balance. 
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The quantity of the sample to be analyzed was around 5 mg and was kept on a silica area.   
 
Figure 21. Rigaku Miniflex 600 equipment 
 
The DSC measurements have been performed by DSC Q2000 device manufactured by TA 
Instruments (New Castle, DE, USA) in order to determine thermal characteristics such as 
degree of crystallinity and melting temperature and enthalpy. These were studied by using TA 
Universal Analysis software. 
For these measurements, an amount of 4-10 mg was weighted and placed in a standard pan. 
Some of the adjustments, such as heating rate, were taken from the equipment manual. The 
procedure used for these measurements can be found in Appendix. 
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Figure 22. TA Instruments DSC Q-2000 equipment 
 
 
 3.2.5 UV-Vis measurements 
 
In order to verify the final nifedipine concentration of every sample, absorbance was 
evaluated. The precise concentration in solution was measured by using a BioSpectrometer® 
from Eppendorf (Hamburg, Germany). 
The spectrophotometer was set at a specific wavelength. The absorbance of the nifedipine was 
measured at 276 nm. The solvent used was acetonitrile. The samples were measured three 
times in order to have reliable data. 
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Figure 23. Eppendorf BioSpectrometer equipment 
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4. Results and discussion  
 
In this section, all the results of the experiments performed are presented. Results from 
suspension balance, DSC, PXDR and spectrophotometer are shown. 
Besides, the influence of every single factor in the solid dispersion is discussed. 
 
4.1 Modeling the phase behavior of API/polymer-formulations 
 
The modeling of the VLEs was determined in this thesis using the PC-SAFT state 
equilibrium. In order to model the system was necessary the pure substance parameters and 
binary interaction parameters.  The pure substance parameters used for the modeling are listed 
in Table 3. In addition to the required pure substance parameters, the binary interaction 
parameters kij for NIF-water, NIF-PVAC, NIF- Resomer R203s and the polymers with water 
were also required. The parameters used for modeling are listed in Table 4.  
 
 
Table 3. PC-SAFT NIF parameter 
 NIF 
Molecular weight 346.36 
Segment number  (mol/g) 0.023474382 
Segment diameter     (A) 3.581025 
Dispersion energy     (K) 309.4425 
Association energy       (-) 1221.582 
Association volume       (K) 0.02 
Melting temperature (°C) 172 
Melting enthalpy (J/mol) 39890 
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Table 4. Binary interaction parameters 
 kij 
kNIF-water 0.011 
kNIF-PVAC -0.0182717 
kwater-PVAC -0.172 
kNIF-Resomer 0.009 
kwater-Resomer 0 
 
The pure substance and binary parameters presented above arise from adjusting the 
experimental from [25] to the theoretical model. In the Figure 24 below, it can be seen the 
adjustment of the data with the parameters presented above. 
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Figure 24. Fitting of the experimental and VLE NIF curves [25] 
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4.2 Predicting the influence of humidity on the phase behavior 
 
Amorphous API formulations are prone to absorb water from the surrounding atmosphere. 
This water absorption leads to a crystallization of the NIF, which is a fact to avoid in order to 
keep the properties and bioavailability achieved with the amorphous state. 
For this purpose, it is an important issue to predict the effect of humidity on the system 
behavior. Therefore it was studied the water sorption of the samples depending on the relative 
humidity and temperature under which the samples were being tested. 
Sorption diagrams for 60%, 75% and 90% of relative humidity are shown in the next Figures 
23, 24 and 25. 
As it can be observed, there is a vast contrast between the humidities. At a 75% RH, the 
sample is able to absorb a maximum value of water of 0,024 in the amorphous state, while at 
90% RH it is able to assimilate 0.047 of water and at 60% RH a maximum value of 0.015. 
The upper line, represented by triangles, corresponds to the water content accepted by the 
amorphous formulation and the lower line corresponds to the water content accepted by the 
crystalline formulation. In this way, it is understood the shape of the Figure 10 in which a 
maximum water value is obtained in the amorphous state and as the crystallization advances 
the water content decreases. 
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Figure 25. Sorption diagram for sample wNIF 80%, 40°C, 60°RH 
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Figure 26. Sorption diagram for sample wNIF 80%, 40°C, 75°RH 
0,0 0,2 0,4 0,6 0,8 1,0
0,00
0,01
0,02
0,03
0,04
0,05
0,06
 
 w
NIF
 80%, 40°C, 90% RH
w
NIF
wH
2
O
 
Figure 27. Sorption diagram for sample wNIF 80%, 40°C, 90°RH 
 
Based on these data, it is easily predictable that there will be a sizeable difference both in time 
required to reach the equilibrium and initial and final water value between the samples. 
 
On the other hand, as it can be seen in the Figures 26 and 27 below, the temperature does not have 
a substantial effect as the RH. Even thought, a higher temperature means a higher water sorption. 
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Figure 28. Sorption diagram for sample wNIF 80%, 35°C, 75°RH 
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Figure 29. Sorption diagram for sample wNIF 80%, 30°C, 75°RH 
 
4.3 Results of suspension balance experiments 
 
The solid dispersions were placed under the desired conditions of temperature and pressure in 
the suspension balance. 
Firstly, it was decided to set a sample and conditions as a point of reference. This was an NIF 
weight fraction of 80%, a temperature of 40 °C and a RH of 75%. And in order to guarantee 
its reproducibility, the experiment was repeated twice. In order to have the same 
thermodynamic history for all the samples, the same steps were always followed to achieve it. 
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The data collected from the balance system are weight of the sample and the cell where the 
powder is; it was also weighted the cell empty. From this weight of the cell and powder and 
the weight of the cell itself, it can be calculated the water content in the sample. 
 
As it can be seen in Figure 30, both experiments overlap each other reaching the same water 
content at the beginning and at the end and achieving the equilibrium at the same time.  
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Figure 30. Overlap of the two independent water sorption measurements obtained for wNIF=0.80 at 40 
°C, 75% RH to check the reproducibility of the experiments 
 
Once this was assured, it was proceeded to study the effect of the influencing factors, always 
taking these values as reference. 
 
 4.3.1 Influence of wNIF 
 
Different weight fractions of the compounds were tested in experiments; these were 90%, 
85%, 80%, 75% and 70% of NIF. The temperature and relative humidity were 40°C and 75%, 
respectively. The results obtained can be seen in Figure 29. 
As it can be observed, there is an evolution in every case. The higher concentration of API in 
the sample, the higher water content is at the beginning and at the ending of the experiment. 
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And also the lower concentration of API the sample contains, the longer it takes to 
crystallizes. 
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Figure 31. Evolution of water content along the weight fraction 
 
In order to avoid the crystallization of NIF, it will be always to work with a low API 
concentration. However, it could be the case that with that weight fraction does not reach the 
recommended dose, in that case it would have to reach a compromise between the weight 
fraction and the improved properties achieved and the recommended dose. On the other side, 
future investigations would go in the direction of studying lower API weight fractions. 
This can be explained, as it was described in 2.3 Influence of RH on the phase behavior, due 
to the shape of the curve in Figure 10. 
 
 4.3.2 Influence of RH 
 
The effect of the relative humidity in the crystallization was also studied. RH of 90%, 75% 
and 60% were analyzed. The conditions under which the experiments were performed were: 
wNIF = 0.80, 40°C of temperature and the corresponding RH.  
The results obtained are shown in Figure 30. 
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Figure 32. Evolution of water content along RH 
 
As it can be observed in the previous plot, there is a sizable difference between the 
experiments both in initial and ending water content and time to reach the equilibrium. The 
higher RH, the higher water absorption, which translates into greater molecular mobility, 
which leads to greater crystallization [35]. 
This behavior was also found in [26].  
 
 4.3.3 Influence of Temperature 
 
Another influencing factor that has been analyzed is the temperature. The temperatures 
studied were 30, 35 and 40 °C with NIF weight fractions of 90, 80 and 70%. The RH was 
75%. The values acquired are shown in Figure 33,34 and 35 
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Figure 33. Evolution of water content along temperature for wNIF 90% and 75%RH 
 
As it is observed in Figure 33, the temperature affects the crystallization time. Comparing the 
temperatures with our reference of 40°C, it is perceived an appreciable difference between 
them.  
 
0 25 50 75 100 125 150
0,000
0,005
0,010
0,015
0,020
0,025
0,030
0,035
w
NIF
=80%, 35°C
 
 
w
NIF
=80%, 40°C
Water content
(%)
Time (h)
w
NIF
=80%, 30°C
 
Figure 34. Evolution of water content along temperature for wNIF 80% and 75%RH 
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In the case of wNIF of 80% shown in Figure 34, the difference is even greater than before as it 
was reached a week time without the 30 °C curve began to decline.  
For the 70% NIF sample observed in Figure 35, it can be seen a considerable difference again. 
In this NIF weight fraction, the experiment was not performed at 30 °C as it would have been 
obtained a straight line similar to the 35°C line. 
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Figure 35. Evolution of water content along temperature for wNIF 70% and 75%RH 
 
According to the results, the temperature conditions in order to prevent crystal formation are 
the lowest possible temperature. 
 
 4.3.4 Influence of polymer type 
 
Another influencing factor studied was the polymer type. It was studied 2 polymers: 
Resomer® R203 S and PVAC. Regarding to the final polymer, this was investigated 2 
different molecular weights. The results can be seen in Figure 36. 
As it is shown, there is a contrast between the two polymers in both the crystallization time 
and water content. The polymer Resomer® R203 S took less time to crystallize and reached 
lower values of sorbed water. 
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It can be also noticed the different behavior between the polymer with differing molecular 
weight although they accomplished the same initial and ending water content. 
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Figure 36. Evolution of water content along polymer for wNIF 80%, 40°C and 75%RH 
 
4.3.5 Influence of the method to prepare the formulation 
 
The last influencing factor studied was the method used in order to prepare the formulation. 
Two forms of preparation were taken into account: spray drying, as the method used in all the 
experiments performed, and melting cooling as the method used in real manufacturing. 
The results are shown in Figure 37.  
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Figure 37. Evolution of water content along the method to prepare the formulation for wNIF 80%, 
40°C and 75%RH 
 
In Figure 37, it can be seen that almost the same initial and ending values of water content are 
achieved. 
On the other side, the difference in time to crystallize is appreciable. The time needed for the 
sample made by melting process is lower than the spray drying sample.  
This is an interesting issue since it is question of avoiding crystallization in time, and this 
melting cooling is the method used in industry. 
 
Calculation of crystallinity via mass balance 
 
Once the suspension balance experiments were done, from the water content data obtained 
from them, it was proceeded to calculate the degree of crystallinity by mass balances. 
In the next Table 5, it can be seen the results of it.  
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Table 5. Degree of crystallinity of the samples by mass balances 
Polymer wNIF (%) T (°C) RH (%) wCrystals (%) 
PVAC 90 40 75 89 
PVAC 80 40 75 73 
PVAC 70 40 75 63 
PVAC 90 35 75 86 
PVAC 80 35 75 72 
PVAC 70 35 75 18 
PVAC 90 30 75 90 
PVAC 80 30 75 6 
PVAC 80 40 90 79 
PVAC 80 40 60 74 
PVAC350 80 40 75 73 
Resomer 203s 90 40 75 87 
Resomer 203s 80 40 75 82 
Resomer 203s 70 40 75 70 
PVAC 85 40 75 76 
PVAC 75 40 75 69 
PVAC Meltcool 80 40 75 74 
PVAC Meltcool 70 40 75 60 
 
As it can be observed in the previous Table 5 the higher degree of crystallinity was reached 
always with a wNIF of 90%. It is also noted that the way of preparation of the formulation 
(spray drying or melting-cooling) does not interfere in the crystallinity achieved even though 
it does interfere in the process of absorbing water. 
 
The progress of the different concentrations in the system can be observed in the next Figure 
38 and 39 for the reference sample (wNIF 0.80, 40°C, 75% RH). It is appreciable that the drop 
of the API in the liquid phase coincides with the increase of crystal growth and at the same 
time an increase of the polymer concentration in the liquid phase. 
 
45 
 
0 10 20 30 40 50 60 70
0,0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1,0
 
 
W
Time (h)
wPol in L
wAPIF in L
wH
2
O L
 
Figure 38. Concentration of compounds in the liquid phase for reference sample (wNIF 80%, 40°C, 
75%RH) 
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Figure 39. Evolution of concentration of crystals, water and API for reference sample (wNIF 80%, 
40°C, 75%RH) 
 
According to what was seen in previous sections, as the water content decreases, the degree of 
crystallization of the sample increases so the NIF content in the liquid phase decreases, as it 
can be observed in Figure 39. 
 
The plots of the development of concentrations for the rest of the samples can be seen in 
Appendix. 
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4.4 Results of PXRD and DSC-measurements 
 
During this chapter it will be shown the results of the PXRD and DSC measurements. By 
performing these experiments, it was wanted to guarantee the amorphous state of the sample 
right after the spray drying and before the experiment in the suspension balance and the 
crystalline state after the suspension balance. It was also wanted to calculate the melting 
enthalpy and therefore verify the degree of crystallinity. 
In the next Figures 40 and 41, it is shown the results from PXRD in which the amorphous and 
crystalline states of the reference sample can be seen, that is wNIF of 80%, 40°C and 75% of 
RH. 
 
Figure 40. PXRD pattern of amorphous state of sample wNIF 80% 
 
 
Figure 41. PXDR pattern of crystalline state of sample wNIF 80%, 40ºC and 75%RH 
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According to the PXRD patters obtained and comparing them to the PXRD patterns from 
literature (Figure 18) of the different polymorphs of nifedipine, it is proved that the 
polymorph produced is the β nifedipine when enough time was given. However, when not 
enough time was given or the NIF weight fraction was 90 or 80%, a mixture of α and β is 
found. This can be noticed in the differences of crystallinity seen in Table 5 and 6. 
 
The enthalpy of fusion or heat of fusion (Δhfus) is the amount of energy required to make an 
element at its melting point pass from the solid state to the liquid at constant pressure.  
The melting enthalpy is a latent heat since during the process of change of state there is no 
appreciable change in temperature. Heat is completely inverted in modifying the structure of 
the material to give mobility to its molecular units. 
This melting enthalpy obtained from the literature, as it was said in 3.1 Materials, was 
compared to the melting enthalpy from the DSC measurements in order to calculate the 
degree of crystallinity and verify whether the results are as expected. 
This data are shown in Table 6 in which it can be seen the operating conditions, the melting 
enthalpy obtained and the degree of crystallization calculated. 
 
Table 6. Melting enthalpies obtained by DSC measurements 
Polymer wAPI 
(%) 
T (°C) RH (%) Melting 
enthalpy (J/g) 
Degree of 
crystallinity (%) 
PVAC 90 40 75 70.42 67.71 
PVAC 80 40 75 65.15 91.76 
PVAC 70 40 75 49.01 69.03 
PVAC 90 35 75 72.88 70.08 
PVAC 80 35 75 63.40 89.30 
PVAC 70 35 75 46.02 64.82 
PVAC 90 30 75 81.12 78 
PVAC 80 40 90 57.49 80.98 
PVAC 80 40 60 33.76 47.55 
PVAC350 80 40 75 58.23 82.02 
Resomer 
203s 
90 40 75 82.38 79.21 
Resomer 
203s 
80 40 75 63.95 90.07 
Resomer 
203s 
70 40 75 49.33 69.48 
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4.5 Results of UV-Vis measurements 
 
After performing the experiments, it was measured the homogeneity of the samples by 
spectrophotometry. As the distribution of the concentration of the powder in a solid dispersion 
is not certainly ideal owing to possible interferences during the preparation, formation or 
experiment, it is necessary to calculate the homogeneity of each sample. 
The results of the measurements are shown in Table 7. 
 
Table 7. Results from UV-Vis measurements 
Sample wAPI (from UV-VIS) (%) 
wNIF 90, 35°C, 75%RH 73.58 
wNIF 90, 40°C, 75%RH 90.07 
wNIF 90,Resomer R203s, 40°C, 75%RH 77.54 
wNIF 90, PVAC350, 35°C, 75%RH 72.98 
wNIF 85, 40°C, 75%RH 82.68 
wNIF 80, 40°C, 75%RH 78.99 
wNIF 80, PVAC350, 40°C, 75%RH 63.53 
wNIF 80,Resomer R203s, 40°C, 75%RH 77.09 
wNIF 80,Melting-Cooling, 40°C, 75%RH 82.55 
wNIF 80,Melting-Cooling, 40°C, 75%RH 77.60 
wNIF 80, PVAC350, 40°C, 75%RH 82.42 
wNIF 80, 40°C, 75%RH 79.77 
wNIF 80, 40°C, 75%RH 76.30 
wNIF 80, 40°C, 60%RH 71.39 
wNIF 75, 40°C, 75%RH 73.48 
wNIF 70, 40°C, 75%RH 56.84 
wNIF 70, 40°C, 75%RH 59.10 
wNIF 70,Melting-Cooling, 40°C, 75%RH 73.98 
wNIF 70,Resomer R203s, 40°C, 75%RH 66.07 
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As it can be seen, most of the samples fulfill the API concentration weighted in at the 
beginning of the experiments. 
The absorbances and the calibration curve are in the Appendixes. 
 
4.6 Determination of Avrami-coefficients 
 
In this chapter it will be discussed the coefficients required to fit the experimental curve with 
the theoretical curve from Avrami equation. As it has been said in a previous section 4.3 
Results of suspension balance experiments, a complete crystallization was not achieved in any 
case, nonetheless the setting of the parameters in all cases is good. 
In the next Figure 42, it can be seen how the two curves in the standard case fit together. This 
has been done for every experiment and the results appear in Appendix. The green curve 
corresponds to the theoretical curve and the blue one to the experimental. 
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Figure 42. Coupling of the experimental curve and Avrami theoretical curve 
 
Among the parameters to adjust, the n coefficient was set to be constant and equal to 4 as it 
represents a crystal growth in three dimensions. The K coefficient was variable in every 
experiment. 
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 4.6.1 Influence of wNIF 
 
The effect on the K coefficient because of the NIF weight fraction can be observed in the next 
Tables 8. The higher API weight fraction on the sample, the higher the K parameters are. This 
is because the K parameter has a directly influence in the speed to reach the equilibrium. 
Therefore, higher API weight fraction means less time to achieve the equilibrium, which 
means higher K parameter. 
 
Table 8. K coefficients with API weight fraction variation 
wNIF K parameter 
90 1.16E-02 
85 2.39E-05 
80 2.05E-06 
75 9.46E-07 
70 6.32E-07 
 
It is noted an exponential behavior on the coefficient as it can be observed in the next Figure 
43. 
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Figure 43. K coefficient behavior with API weight fraction 
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 4.6.2 Influence of RH 
 
Regarding to the effect of relative humidity on the Avrami parameters, it is noted again an 
exponential behavior as it occurs in the study of weight fraction. This performance can be 
seen in Figure 44. 
The higher relative humidity under which the experiment was carried out, the higher the K 
parameters are. 
 
Table 9. K coefficients with relative humidity variation 
Relative Humidity K parameter 
60 2.20E-07 
75 2.05E-06 
90 1.00E-02 
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Figure 44. K coefficient behavior with relative humidity 
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 4.6.3 Influence of Temperature 
 
Another influencing factor studied was the temperature and the experimental K coefficients 
collected can be seen in Figure 45. In that image, it is noted an exponential conduct as in the 
previous cases. 
The higher temperature under which the experiment was carried out, the higher the K 
parameters are. 
Table 10. K coefficients with temperature variation for wNIF 90% 
Temperature (°C) K parameter 
30 4.50E-08 
35 2.97E-06 
40 1.16E-02 
 
Table 11. K coefficients with temperature variation for wNIF 80% 
Temperature (°C) K parameter 
35 2.70E-07 
40 2.05E-06 
 
Table 12. K coefficients with temperature variation for wNIF 70% 
Temperature (°C) K parameter 
35 6.32E-07 
40 2.05E-06 
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Figure 45. K coefficient behavior as function of temperature 
 
This in line with expectations, that is to say, the higher the temperature was in the 
experiments, the lower time was required to fully recrystallize so that it was expected to have 
a greater coefficient. 
 
 4.6.4 Influence of polymer type 
 
With respect to the effect of the polymer which has been used, it was studied the two 
polymers presented before: PVAC and Resomer. As it was seen in section 4.3, there is a 
difference in the time of crystallization between the two polymers, what it was also brought to 
the K parameters. The less time to crystallize, the lower K coefficient is.  
Regarding the operating conditions, the NIF weight fraction was 80%, the temperature was 40 
ºC and the RH was 75%. 
 
Table 13. K coefficients with polymer variation 
Polymer K parameter 
Resomer R203s 5.02E-04 
PVAC 2.05E-06 
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4.6.5 Influence of the method to prepare the formulation 
 
About the modeling by Avrami according to the preparation of the formulation, it can be said 
that the value is the expected in the sense that is lower than the one obtained from the spray 
drying as the time required to crystallize is also lower.  
The two methods of preparing the formulation studied were spray drying and melting method. 
Regarding the operating conditions, these were wNIF 80%, 40 ºC and 75% RH. 
 
Table 14. K coefficients with method of preparation variation 
Method of preparation K parameter 
Melting method 3.08E-05 
Spray drying 2.05E-06 
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5. Conclusion  
 
The aim of this project was to study the crystallization of the NIF by observing the water 
content absorbed and analyzing different influencing factors as NIF weight fraction, 
temperature, RH, polymer and method to prepare the formulation. 
From the resulting data obtained from the study of them, several conclusions have been 
reached. 
First of all, in no case complete crystallization has been achieved. This may be due to a lack 
of sufficient time to accomplish it. 
After spray drying or melting method, the results show that the solid dispersions were totally 
amorphous. Both the suspension balance experiments and DSC and PXRD measurements 
have proven to be perfect instruments to study the crystallization of API. 
About the NIF polymorphs which are formed, it has been noted that β NIF is the 
predominantly formed, especially with API weight fraction of 70% and enough time to reach 
the equilibrium and crystallize. It can be also recognized a mixture of α and β nifedipine when 
the NIF weight fraction is 90% and 80%. 
The Avrami equation has proved its validity to model the behavior followed by the 
crystallization. The parameters obtained agree with the results achieved from the suspension 
balance experiments. It has been shown that the assumption of n parameter equal to 4, which 
is crystal growth in 3 dimensions, is correct. 
With respect to the influencing factors studied, some conclusions have come to the fore. 
According to the API weight fraction, the lower API concentration the sample contains, the 
longer it takes to crystallize. The higher concentration of API in the sample, the higher water 
content is at the beginning and at the ending of the experiment. It could be the case that with 
that weight fraction does not reach the recommended dose, in that case it would have to reach 
a compromise between the weight fraction and the improved properties achieved and the 
recommended dose. On the other side, future investigations would go in the direction of 
studying lower API weight fractions.  
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In terms of relative humidity, a huge difference occurs among the several relative humidities 
that have been implemented. These differences translate into variations in the time required to 
reach the equilibrium and crystallize and the initial and final water content. 
Regarding to the temperature, the lower temperature under the sample is at, the longer it takes 
to crystallize. Thereby, in order to avoid crystallization, it is necessary to store under a 
minimum temperature. 
In respect of the method to prepare the formulation, differences in time to crystallize emerged. 
Thus, the time needed for the melting method, the method normally used in industry, is less 
than the time required for spray drying method. In this manner, in order to avoid 
crystallization, it might be considered a way to use and optimize the spray drying method on a 
large scale. 
Respecting the polymer used in the formulation, it was noticed that PVAC retarded the time 
to crystallize so that it better fulfills the purpose of avoiding crystallization than Resomer 
R203s. In further investigations, more polymers will have to be studied in order to find the 
optimum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
57 
 
Appendix  
 
Preparation of formulations via spray drying 
 
Table 15. Measurements in the spray drying process 
Weight NIF (g) Weight polymer (g) Polymer Tin (°C) Tout (°C) 
0.4491 0.0497 PVAC 60 37 
0.3991 0.1005 PVAC 60 33 
0.7025 0.3002 PVAC 60 41 
1.2075 0.8014 PVAC 60 39 
0.9079 0.1002 PVAC 60 38 
0.8071 0.1995 PVAC 60 38 
0.9014 0.1014 PVAC 60 37 
0.7054 0.3064 PVAC 60 37 
0.8038 0.2003 PVAC 60 39 
0.8043 0.2002 PVAC 60 37 
0.7990 0.1995 PVAC 60 35 
0.8010 0.1995 PVAC350 60 35 
0.8028 0.2012 PVAC350 60 39 
0.8033 0.2024 PVAC350 60 37 
0.9038 0.1038 PVAC350 60 38 
0.8140 0.2001 Resomer 203s 60 40 
0.7060 0.3006 Resomer 203s 60 40 
0.9071 0.1009 Resomer 203s 60 39 
0.9071 0.1017 Resomer 203s 60 39 
0.8567 0.1585 PVAC 60 36 
0.7506 0.2518 PVAC 60 36 
0.8026 0.2018 PVAC 60 36 
0.8016 0.2016 PVAC 60 35 
0.8047 0.2023 PVAC350 60 37 
0.9015 0.1007 PVAC 60 39 
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Calculation of crystallinity via mass balance 
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Figure 46. Concentration of components in the liquid phase for sample wNIF 0.90, 40°C, 75%RH 
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Figure 47. Evolution of concentration of crystals, water and API for sample wNIF 0.90, 40°C, 75%RH 
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Figure 48. Concentration of components in the liquid phase for sample wNIF 0.70, 40°C, 75%RH 
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Figure 49. Evolution of concentration of crystals, water and API for sample wNIF 0.70, 40°C, 75%RH 
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Figure 50. Concentration of components in the liquid phase for sample wNIF 0.85, 40°C, 75%RH 
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Figure 51. Evolution of concentration of crystals, water and API for sample wNIF 0.85, 40°C, 75%RH 
60 
 
 
0 10 20 30 40 50 60 70
0,0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1,0
 
 
W
Time (h)
wPol in L
wAPIF in L
wH
2
O L
 
Figure 52. Concentration of components in the liquid phase for sample wNIF 0.75, 40°C, 75%RH 
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Figure 53. Evolution of concentration of crystals, water and API for sample wNIF 0.75, 40°C, 75%RH 
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Figure 54. Concentration of components in the liquid phase for sample wNIF 0.80, 40°C, 75%RH by 
melting-cooling 
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Figure 55. Evolution of concentration of crystals, water and API for sample wNIF 0.80, 40°C, 75%RH 
by melting-cooling 
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Figure 56. Concentration of components in the liquid phase for sample wNIF 0.80, 40°C, 90%RH 
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Figure 57. Evolution of concentration of crystals, water and API for sample wNIF 0.80, 40°C, 90%RH 
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Figure 58. Concentration of components in the liquid phase for sample wNIF 0.80, 40°C, 60%RH 
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Figure 59. Evolution of concentration of crystals, water and API for sample wNIF 0.80, 40°C, 60%RH 
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Figure 60. Concentration of components in the liquid phase for sample wNIF 0.90, 30°C, 75%RH 
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Figure 61. Evolution of concentration of crystals, water and API for sample wNIF 0.90, 30°C, 75%RH 
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Figure 62. Concentration of components in the liquid phase for sample wNIF 0.90, 35°C, 75%RH 
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Figure 63. Evolution of concentration of crystals, water and API for sample wNIF 0.90, 35°C, 75%RH 
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Figure 64. Concentration of components in the liquid phase for sample wNIF 0.80, 35°C, 75%RH 
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Figure 65. Evolution of concentration of crystals, water and API for sample wNIF 0.80, 35°C, 75%RH 
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Figure 66. Concentration of components in the liquid phase for sample wNIF 0.80, 30°C, 75%RH 
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Figure 67. Evolution of concentration of crystals, water and API for sample wNIF 0.80, 30°C, 75%RH 
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Figure 68. Concentration of components in the liquid phase for sample wNIF 0.70, 35°C, 75%RH 
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Figure 69. Evolution of concentration of crystals, water and API for sample wNIF 0.70, 35°C, 75%RH 
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Figure 70. Concentration of components in the liquid phase for sample wNIF 0.90 in Resomer R203s, 
40°C, 75%RH 
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Figure 71. Evolution of concentration of crystals, water and API for sample wNIF 0.90 in Resomer 
R203s, 40°C, 75%RH 
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Figure 72. Concentration of components in the liquid phase for sample wNIF 0.80 in Resomer R203s, 
40°C, 75%RH 
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Figure 73. Evolution of concentration of crystals, water and API for sample wNIF 0.80 in Resomer 
R203s, 40°C, 75%RH 
0 5 10 15 20 25 30 35 40 45
0,0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1,0
 
 
W
Time (h)
wPol in L
wAPIF in L
wH
2
O L
 
Figure 74. Concentration of components in the liquid phase for sample wNIF 0.70 in Resomer R203s, 
40°C, 75%RH 
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Figure 75. Evolution of concentration of crystals, water and API for sample wNIF 0.70 in Resomer 
R203s, 40°C, 75%RH 
68 
 
 
Verification of crystallinity via PXRD and DSC 
 
DSC measurements 
Table 16. Data about samples and their DSC measurements 
 
 
 
 
 
Polymer 
wNIF 
(%) 
Weight 
(mg) 
T (°C) 
RH 
(%) 
Enthalpy 
of fusion 
(J/g) 
Standard 
deviation 
Enthalpy of 
fusion (J/g) 
Reverse heat 
flow (J/g) 
Standard 
deviation 
Reverse heat 
flow (J/g) 
PVAC 90 
2.2 
4.6 
40 75 70.42 7.28 88.42 9.64 
PVAC 80 
4.4 
4.4 
40 75 65.15 0.30 72.80 0.40 
PVAC 70 
7.4 
7.6 
40 75 49.01 1.29 48.59 6.65 
PVAC 90 
6.1 
8.0 
35 75 72.88 0.54 67.11 21.31 
PVAC 80 
5.1 
5.6 
35 75 63.40 2.51 57.35 5.85 
PVAC 70 
6.0 
7.5 
35 75 46.02 1.70 40.43 9.75 
PVAC 90 
5.4 
5.4 
30 75 81.12 3.13 84.36 59.59 
PVAC 80 
7.8 
7.1 
40 90 57.49 1.76 49.62 19.78 
PVAC 80 
5.0 
4.3 
40 60 33.76 6.05 37.51 1.97 
PVAC350 80 
5.8 
4.3 
40 75 58.23 2.21 48.01 17.74 
Resomer 
203s 
90 
7.5 
7.1 
40 75 82.38 2.51 56.41 25.75 
Resomer 
203s 
80 
8.2 
7.9 
40 75 63.95 1.41 50.67 1.59 
Resomer 
203s 
70 
6.4 
6.2 
40 75 49.33 4.54 51.89 7.13 
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DSC method 
 
Table 17. DSC method 
DSC method 
Data storage Off 
Equilibrate at 0.00 ºC 
Isothermal for 5.00 min 
Data storage On 
Modulate ± 0.796 ºC every 60 s 
Ramp 5.00 °C/min to 200.00 °C 
Data storage Off 
Isothermal for 5.00 min 
Data storage On 
Ramp 10.00 ºC/min to 0.00 ºC 
Data storage Off 
Isothermal for 5.00 min 
Data storage On 
Ramp 5.00 ºC/min to 80.00 ºC 
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UV-Vis measurements 
 
Table 18. Recorded absorbances from UV-Vis measurements 
Sample wNIF (mg) Solution (g) A. 1 A. 2 A. 3 
wAPI 90, 35°C, 75%RH 5.4 15.197 2.961 2.958 2.980 
wAPI 90, 40°C, 75%RH 5.4 12.733 2.872 2.879 2.877 
wAPI 90,Resomer R203s, 
40°C, 75%RH 
5.2 15.418 2.512 2.799 2.541 
wAPI 90, PVAC350, 35°C, 
75%RH 
5.1 15.104 2.806 2.807 2.840 
wAPI 85, 40°C, 75%RH 5.2 15.089 2.295 2.322 2.330 
wAPI 80, 40°C, 75%RH 5.1 15.137 2.213 2.212 2.216 
wAPI 80, PVAC350, 40°C, 
75%RH 
5.1 15.171 2.865 2.874 2.881 
wAPI 80,Resomer R203s, 
40°C, 75%RH 
5.2 15.091 2.338 2.344 2.352 
wAPI 80,Melting-Cooling, 
40°C, 75%RH 
5.1 15.193 2.080 2.080 2.095 
wAPI 80,Melting-Cooling, 
40°C, 75%RH 
5.3 15.442 2.325 2.302 2.317 
wAPI 80, PVAC350, 40°C, 
75%RH 
5.1 15.087 2.103 2.105 2.115 
wAPI 80, 40°C, 75%RH 5.1 15.134 2.182 2.188 2.192 
wAPI 80, 40°C, 75%RH 5.1 15.121 2.964 2.978 2.971 
wAPI 80, 40°C, 60%RH 5.6 15.194 2.792 2.781 2.799 
wAPI 75, 40°C, 75%RH 5.2 15.108 2.288 2.293 2.302 
wAPI 70, 40°C, 75%RH 5.2 15.446 2.805 2.787 2.818 
wAPI 70, 40°C, 75%RH 5.2 15.355 2.746 2.651 2.688 
wAPI 70,Melting-Cooling, 
40°C, 75%RH 
5.4 15.101 2.188 2.180 2.202 
wAPI 70,Resomer R203s, 
40°C, 75%RH 
5.2 15.112 2.395 2.396 2.412 
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Calibration curve of UV-VIS Spectrophotometer 
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Figure 76. Calibration curve of NIF at 276 nm in acetonitrile 
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